Larvol Delta - Phase-2-Study-to-Determine-if-RTB101-Reduces-the-Severity-of-COVID19-in-Older-Adults-Residing-in-Nursing-Homes

dactolisib (RTB101) - resTORbio

http://clinicaltrials.gov/ct2/show/NCT04409327

Dec 9, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next